Published: January 2026
Medically reviewed by:
Gary Falcetano, PA-C, AE-C
Food allergies are increasingly common, affecting as many as 250 million people worldwide,1 yet they remain under-recognized in primary care. This leaves patients vulnerable to misdiagnosis, unnecessary food avoidance or in severe cases, anaphylaxis.
Primary care is often the first step for patients experiencing symptoms of a suspected food allergy,2 which is why it is essential for primary care providers (PCPs) to follow a structured, guideline-based approach when evaluating suspected food allergies.
How to choose the right test
Accurate food allergy diagnosis begins with the patient’s history. This should include:3
- Unexplained reactions or adverse events after exposure
- History of food-related discomfort, anxiety or avoidance
- Self-restricted diets or use of online advice
- Recurrent gastrointestinal, skin or respiratory symptoms
This can help determine which patients may benefit from further testing.
Test type matters5
Selecting the correct test is especially pertinent because while 35% of patients self-report a food allergy, only 3.5% have a true clinical allergy. Over-testing without context risks adding confusion rather than clarity.5
Specific IgE blood tests
ImmunoCAP™ whole allergen tests are generally appropriate in primary care, either alongside or instead of skin prick testing.
Component-resolved diagnostics (CRD)
Offer a precise, targeted view of allergen sensitization, helping providers make confident, personalized decisions. Aligned with EAACI / AAAAI guidelines*, CRD supports evidence-based care where deeper insight is needed.
Avoid broad screening panels
Ordering large, non-selective panels without a clear clinical rationale is not recommended by current EAACI guidelines*. Non-selective tests with large numbers of allergens increase the risk of clinically irrelevant false positives.4
Core principles of interpretation
When interpreting food allergen test results, always take into account the patient’s history and symptoms. The following principles are intended as practical guidance to support informed decision-making, not as rigid rules. Testing is only one part of the diagnostic process and should be used to clarify, not complicate, patient care.
Positive results should always be interpreted in the context of patient symptoms to confirm a clinical allergy.
Detectable IgE indicates sensitization, but sensitization alone is not sufficient for diagnosis. Correlation with the patient’s history is essential to distinguish a true clinical allergy from asymptomatic sensitization or cross-reactivity.
Component-resolved diagnostics can improve specificity.
CRDs help clarify whether sensitization is primary or due to cross-reactivity and can indicate potential severity of reactions. Per EAACI guidelines, specific IgE testing is particularly well-established for high-risk allergens like peanut (Ara h 2), hazelnut (Cor a 14) and cashew nut (Ana o 3), though other components may also provide valuable diagnostic insight.6
Quantitative values matter.
Quantitative IgE values provide valuable information about sensitization strength. However, clinical reactivity thresholds vary across allergens and individuals and should be interpreted in context. The higher the level of specific IgE antibodies, the higher the risk for symptomatic allergy.7
Negative results do not completely rule out the possibility of an allergy.
A negative specific IgE test reduces the likelihood of an allergy but does not exclude it. This may occur if the allergen is not included in the test panel, if the reaction is non-IgE mediated, or if the used test system lacks sensitivity. ImmunoCAP whole allergen extract tests are highly sensitive and provide a reliable baseline for evaluation.
Holistic interpretation of specific IgE test results is essential.
In an illustrative case study, we follow Tim, a young boy initially diagnosed with a peanut allergy, which had significantly impacted his life. A better-informed follow-up revealed a peanut allergen sensitization of 2.6 kUA/l and an Ara h 8 allergen sensitization of 2.79 kUA/l.
Tim’s sensitization to Ara h 8 is associated with either no reactions or localized reactions, like itching and tingling of the mouth and lips, but low risk of systemic reaction. Tim may actually be sensitized to birch pollen, which is cross-reactive and responds similarly to Ara h 8. Tim shows no detectable sensitization to four nut storage proteins associated with severe reactions.8,9,10
Asymptomatic sensitization
When specific IgE antibodies are detectable, but the patient shows no symptoms when exposed to the allergen in real life, this is known as asymptomatic sensitization or clinically irrelevant positivity.
Why asymptomatic sensitization occurs:
- Low-level sensitization: Modern testing can detect very small amounts of IgE. While measurable, these levels may be too low in some cases to cause any clinical effect. This is particularly common in children with atopic dermatitis, who may show low-level food sensitizations without corresponding symptoms.
- Cross-reactivity: IgE antibodies may recognize proteins that look similar across unrelated sources. For example, someone sensitized to birch pollen may test positive to apple even if they tolerate apples without any reaction.
- Non-specific binding or technical artifacts: Rarely, laboratory factors can produce signals unrelated to true sensitization.
In short, a positive test result without clinical symptoms does not confirm an allergy. It’s important to always interpret results within the context of a patient’s history.
Sensitivity matters
A negative result makes food allergy less likely, especially when measured with a highly sensitive test such as ImmunoCAP™ Specific IgE tests, which can detect even low IgE levels.
If symptoms persist with a negative test result, the culprit allergen may have been missed. Reassessing the patient’s history and possible exposures can help guide next steps.
Possible reasons for ongoing symptoms despite a negative test result:
- The allergen tested may not include the trigger
- IgE levels may be present, but too low to detect
- The reaction may not be IgE-mediated
A negative test result should not automatically exclude the possibility of allergy, especially when the clinical history strongly suggests a reaction. In such cases, additional diagnostic methods, including confirmatory testing or an oral food challenge, may be necessary.
When to refer to specialist care
Some situations require specialist input to ensure patient safety and appropriate management.
Consider a referral when:2
- Test results are unclear or conflicting
- A severe food allergy or anaphylaxis is suspected
- Immunotherapy is being considered as part of the treatment plan
- There is complex polysensitization (multiple positives across different allergen groups)
- Additional diagnostic evaluation, such as an oral food challenge, is required
- Symptoms are not resolved by primary care management
Working with specialists helps ensure accurate interpretation, reduces the risk of unnecessary food restrictions and supports effective management for patients with more complex allergy profiles.
Clarity that drives better outcomes
Accurate interpretation is as important as ordering the test itself.
Follow a structured approach:6
- Start with a focused history that includes patient symptoms and exposure
- Choose the appropriate test based on that history
- Interpret results carefully, distinguishing true allergy from asymptomatic sensitization or cross-reactivity
- Refer to a specialist when results are complex, unclear or when high-stakes decisions are involved
Keep it practical. Use test results to confirm true allergy, avoid unnecessary dietary restrictions and intervene earlier with confidence.
Explore further educational support and resources on food allergy evaluation in primary care.
* The EAACI (European Academy of Allergy and Clinical Immunology) and the AAAAI (American Academy of Allergy, Asthma & Immunology) are leading international organizations dedicated to advancing research, education, and clinical care in allergy and immunology.
